Interest in Si14 AG holding grows after announced cooperation with BRICS countries

Infoway announced an increase in interest in the Pre-IPO of the Swiss holding Si14 AG after the presentation of the holding’s medical projects at the BRICS and BRICS+ International Summit in Dubai.

The investment attractiveness of Si14 AG shares is growing after the holding introduced patented colloidal nanotechnologies in the pharmaceuticalindustry, according to Infoway Marketing, the official representative of Si14 AG, компании Infoway Marketing.

The company is engaged in the implementation of colloidal technologies in the field of medicine in the BRICS countries. Technologies are implemented through theSi14 Pharmamanagement.

Si14 Pharma specializes in homeopathic steroids, innovative medical equipment, комплекты Life Packs, and dietary supplements based on metallob atomic colloids..

В хThe Si14 AG holding includes 9 innovative areas in the fields of high technology, healthcare, sustainable energy and finance. The company intends to go public in 2026 and continue to actively expand internationally.